We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

Concentra Group Holdings Parent, Inc. (NYSE:CON), the largest provider of occupational health services in the United States with a market capitalization of $2.82 billion, has emerged as a compelling ...